Brainsway Ltd. logo
Brainsway Ltd. BWAY
$ 19.29 -1.73%

Annual report 2024
added 12-13-2025

report update icon

Brainsway Ltd. Income Statement 2011-2025 | BWAY

Annual Income Statement Brainsway Ltd.

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

- - - 240 M 84.6 M 100 M - - - - - - - -

Shares

- - - 31.2 M 11.2 M 10.3 M - - - - - - - -

Historical Prices

8.85 5.15 3.19 7.7 7.54 9.75 - - - - - - - -

Net Income

- - - -6.46 M -5.38 M -10.3 M -6.48 M -7.05 M -2.4 M -4.09 M -6.54 M -7.12 M - -

Revenue

41 M 31.8 M 27.2 M 29.7 M 22.1 M 23.1 M 16.4 M 11.1 M 11.5 M 6.8 M 3.38 M 1.19 M - -

Cost of Revenue

- - - 6.6 M 5.06 M 5.13 M 3.59 M 2.6 M - - - - - -

Gross Profit

30.6 M 23.5 M 20 M 23.1 M 17 M 18 M 12.8 M 8.55 M 9.1 M 5.33 M 2.72 M 990 K - -

Operating Income

- - - -5 M -4.83 M -8.48 M -5.11 M -6.61 M - - - - - -

EBITDA

- - - -5 M -4.83 M -8.48 M -5.11 M -6.61 M -2.02 M -4.48 M -7.27 M -4.26 M - -

Operating Expenses

29.2 M 28.4 M 32.7 M 28.1 M 21.8 M 26.4 M 17.9 M 15.2 M 11.2 M 9.84 M 10 M 5.26 M - -

General and Administrative Expenses

- - - 5.78 M 3.31 M 4.39 M 8.23 M 7.47 M 5.74 M 3.61 M 2.34 M 1.43 M - -

All numbers in USD currency

Quarterly Income Statement Brainsway Ltd.

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

All numbers in USD currency

The income statement is one of the three key financial reports of a company Brainsway Ltd. (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:

  • How much revenue the company earned
  • How much it spent on production, personnel, marketing, taxes, etc.
  • What profit remained in the end

Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.

Features
  • The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
  • Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
  • A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.

Reports on the profits and losses of other stocks in the Diagnostics research industry

Issuer Price % 24h Market Cap Country
Akumin Akumin
AKU
- -17.87 % $ 25.9 M canadaCanada
Centogene N.V. Centogene N.V.
CNTG
- -6.23 % $ 30.6 M germanyGermany
Chembio Diagnostics Chembio Diagnostics
CEMI
- 0.22 % $ 16.8 M usaUSA
Burning Rock Biotech Limited Burning Rock Biotech Limited
BNR
$ 21.26 -2.34 % $ 229 M chinaChina
Accelerate Diagnostics Accelerate Diagnostics
AXDX
- -61.36 % $ 2.46 M usaUSA
Biocept Biocept
BIOC
- -13.05 % $ 7.29 M usaUSA
Castle Biosciences Castle Biosciences
CSTL
$ 40.09 -0.27 % $ 1.11 B usaUSA
DarioHealth Corp. DarioHealth Corp.
DRIO
$ 10.04 -0.99 % $ 285 M israelIsrael
Enzo Biochem Enzo Biochem
ENZ
- -8.98 % $ 14.8 K usaUSA
BioNano Genomics BioNano Genomics
BNGO
$ 1.52 -0.65 % $ 1.93 M usaUSA
Danaher Corporation Danaher Corporation
DHR
$ 231.47 0.28 % $ 169 B usaUSA
DexCom DexCom
DXCM
$ 67.42 0.84 % $ 26 B usaUSA
Exact Sciences Corporation Exact Sciences Corporation
EXAS
$ 101.54 -0.05 % $ 18.8 B usaUSA
Oxford Immunotec Global PLC Oxford Immunotec Global PLC
OXFD
- - $ 562 M britainBritain
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
- -20.0 % $ 1.06 M usaUSA
Fulgent Genetics Fulgent Genetics
FLGT
$ 27.01 -0.55 % $ 817 M usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
- - $ 399 M chinaChina
Fluidigm Corporation Fluidigm Corporation
FLDM
- 1.08 % $ 308 M usaUSA
Genetic Technologies Limited Genetic Technologies Limited
GENE
- - $ 7.1 B australiaAustralia
Genetron Holdings Limited Genetron Holdings Limited
GTH
- 0.12 % $ 80.1 M chinaChina
DermTech DermTech
DMTK
- -11.32 % $ 2.94 M usaUSA
PRA Health Sciences, Inc. PRA Health Sciences, Inc.
PRAH
- - $ 10.7 B usaUSA
CareDx, Inc CareDx, Inc
CDNA
$ 19.73 -1.45 % $ 1.06 B usaUSA
Celcuity Celcuity
CELC
$ 102.61 0.25 % $ 4.05 B usaUSA
Anixa Biosciences Anixa Biosciences
ANIX
$ 3.42 3.64 % $ 109 K usaUSA
Co-Diagnostics Co-Diagnostics
CODX
$ 0.24 -1.79 % $ 7.04 M usaUSA
IQVIA Holdings IQVIA Holdings
IQV
$ 226.02 0.39 % $ 41 B usaUSA
Motus GI Holdings Motus GI Holdings
MOTS
- -34.28 % $ 263 K israelIsrael
Guardant Health Guardant Health
GH
$ 102.38 -0.12 % $ 12.6 B usaUSA
NeoGenomics NeoGenomics
NEO
$ 12.3 -0.97 % $ 1.56 B usaUSA
Aspira Women's Health Aspira Women's Health
AWH
- -6.19 % $ 10.5 M usaUSA
Neogen Corporation Neogen Corporation
NEOG
$ 7.14 -0.14 % $ 1.55 B usaUSA
National Research Corporation National Research Corporation
NRC
$ 18.81 -1.05 % $ 462 M usaUSA
Heska Corporation Heska Corporation
HSKA
- - $ 1.31 B usaUSA
Organovo Holdings Organovo Holdings
ONVO
- -2.3 % $ 19.4 M usaUSA
OpGen OpGen
OPGN
- -16.95 % $ 1.54 M usaUSA
OPKO Health OPKO Health
OPK
$ 1.3 -0.76 % $ 902 M usaUSA
Mettler-Toledo International Mettler-Toledo International
MTD
$ 1 417.16 0.18 % $ 30.1 B schweizSchweiz
Illumina Illumina
ILMN
$ 135.32 -0.64 % $ 21.5 B usaUSA
Charles River Laboratories International Charles River Laboratories International
CRL
$ 203.16 0.14 % $ 10.4 B usaUSA
ENDRA Life Sciences ENDRA Life Sciences
NDRA
$ 5.1 - $ 2.74 M usaUSA
Pacific Biosciences of California Pacific Biosciences of California
PACB
$ 1.88 3.3 % $ 477 M usaUSA
Koninklijke Philips N.V. Koninklijke Philips N.V.
PHG
$ 26.98 0.37 % $ 20 B niderlandNiderland
PerkinElmer PerkinElmer
PKI
- -0.91 % $ 14.7 B usaUSA
Quest Diagnostics Incorporated Quest Diagnostics Incorporated
DGX
$ 175.92 0.48 % $ 19.5 B usaUSA
Biodesix Biodesix
BDSX
$ 6.82 1.04 % $ 884 M usaUSA
Personalis Personalis
PSNL
$ 8.41 -0.12 % $ 498 M usaUSA
Quidel Corporation Quidel Corporation
QDEL
$ 28.91 1.12 % $ 1.22 B usaUSA
Precipio Precipio
PRPO
$ 23.89 2.56 % $ 31 M usaUSA